MM
RDY icon

MQS Management’s Dr. Reddy's Laboratories RDY Stock Holding History

MQS Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,392
Closed -$185K – 449
2026
Q1 		$185K Buy
+13,392
New +$186K 0.13% 347
2024
Q1 		– Sell
-16,160
Closed -$225K – 644
2023
Q4 		$225K Sell
16,160
-3,850
-19% -$51.5K 0.12% 349
2023
Q3 		$268K Buy
+20,010
New +$271K 0.16% 280
2023
Q1 		– Sell
-45,220
Closed -$468K – 564
2022
Q4 		$468K Buy
+45,220
New +$488K 0.32% 111

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

MQS Management's RDY Position: Q2 2026 in Review

MQS Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 13,392 shares — an estimated $185K sold.

MQS Management first reported a position in RDY in Q4 2022 and held it in 4 quarters. The position peaked at $468K in Q4 2022. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • MQS Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • MQS Management sold 13,392 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $185K.
  • MQS Management first reported a position in Dr. Reddy's Laboratories in Q4 2022 and held it in 4 quarters.
  • MQS Management's Dr. Reddy's Laboratories position peaked at $468K in Q4 2022.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.